The 4Ts scoring system for heparin-induced thrombocytopenia in medical-surgical intensive care unit patients.
about
Venous thromboembolic diseaseMechanical circulatory assist devices: a primer for critical care and emergency physiciansHeparin induced thrombocytopenia in critically ill: Diagnostic dilemmas and management conundrumsUnfractionated heparin for hemodialysis: still the best option.Assessment of the 4Ts pretest clinical scoring system as a predictor of heparin-induced thrombocytopenia.Evaluation of empiric versus nomogram-based direct thrombin inhibitor management in patients with suspected heparin-induced thrombocytopenia.Rapid exclusion or confirmation of heparin-induced thrombocytopenia: a single-center experience with 1,291 patients.Treatment and prevention of heparin-induced thrombocytopenia: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.PF4/heparin antibody testing and treatment of heparin-induced thrombocytopenia in the intensive care unit.Dynamic antibody-binding properties in the pathogenesis of HIT.Predictive value of the 4Ts scoring system for heparin-induced thrombocytopenia: a systematic review and meta-analysis.Contributions of biological tests and the 4 Ts score in the diagnosis of heparin induced thrombocytopenia.Thrombocytopenia in the critically ill: prevalence, incidence, risk factors, and clinical outcomes.Impact of an immunoglobulin G-specific enzyme-linked immunosorbent assay on the management of heparin-induced thrombocytopenia.Prospective observational evaluation of the particle immunofiltration anti-platelet factor 4 rapid assay in MICU patients with thrombocytopenia.Drug-induced thrombocytopenia in the critically ill: a case-control study.Repeated early hemofiltration filters clotting and heparin-induced thrombocytopenia in ICU.Prevalence and clinical implications of anti-PF4/heparin antibodies in intensive care patients: a prospective observational study.Over-testing for heparin induced thrombocytopenia in hospitalized patients.Is the incidence trend of heparin-induced thrombocytopenia decreased by the increased use of low-molecular-weight-heparin?Treatment of heparin-induced thrombocytopenia before and after the implementation of a hemostatic and antithrombotic stewardship program.Diagnostic accuracy of IgG-specific versus polyspecific enzyme-linked immunoassays in heparin-induced thrombocytopenia: a systematic review and meta-analysis.Functional Assays in the Diagnosis of Heparin-Induced Thrombocytopenia: A Review.Comparisons of argatroban to lepirudin and bivalirudin in the treatment of heparin-induced thrombocytopenia: a systematic review and meta-analysis.Influence of human leukocyte antigen (HLA) alleles and killer cell immunoglobulin-like receptors (KIR) types on heparin-induced thrombocytopenia (HIT).Desirudin: a review of the pharmacology and clinical application for the prevention of deep vein thrombosis.The Role of Single-Molecule Force Spectroscopy in Unraveling Typical and Autoimmune Heparin-induced Thrombocytopenia.Experts' opinion or the serotonin release assay as a gold standard for the diagnosis of heparin-induced thrombocytopenia (HIT)?
P2860
Q24631121-D44BBB4F-181A-4C6C-A96E-E3172FF95DF0Q26747170-298A7984-676F-48FB-847C-941CE671E201Q26799395-AB6DF6E5-6B69-4472-9033-E41BCF85BE61Q33392592-9931F91F-EF77-4643-B07C-43D3F37CA4E7Q33393894-9FCBF771-25A0-4CAC-953A-5C1425BCE7E0Q33394199-E8F6B262-4072-4DE4-BBC0-4991906626E9Q33397294-B5C6088A-D5F2-4B94-AD39-BFB22263489EQ33399580-F1BA7D9B-067B-41E2-8424-AFDA90605764Q33400056-C2FD9FF3-1F3A-4BB9-A67A-D9AEEDC21A67Q33401163-78E53C44-CC25-47A0-9316-B0FEEE623D64Q33403395-4A59726A-C5B2-4665-AA5B-A29AD7B9F4E3Q33405248-DD9C262F-EEDD-44FE-9D58-A8C929D5A1B1Q33407272-4AE2F3F3-8A94-4324-9FC6-21D7D78FDDA6Q33408778-FFD0B7BD-FBE1-4586-94D9-53EDC3E16761Q33409277-6E83B6E9-D4EE-4E7B-99DF-094FBDF4971AQ33414170-17EB74F5-7EA4-4614-9C0F-CE94B5C766A9Q33415852-D3F24084-8B6C-4514-B1B0-AA5125D359B8Q33416315-2CE5EB47-D858-4B16-859E-453E6E3AE46AQ33417093-EEAF4C1B-3573-4135-AA4A-FAC7AB1BCEC9Q33422736-2AB9CFBA-DA4B-47B0-A76B-57AAD4F0CC23Q33434438-4C9FDA48-7E33-4D42-ABCF-CFB0873A25A7Q33440663-CB837C4B-4AA5-4080-9FE9-952C033ABA36Q33440890-E7CDD96F-448B-4E3B-8137-94A99E84A12FQ33442600-22B4117A-9C5C-4D99-BEBD-DDD8804C61E5Q33443448-20E2D20A-1226-420D-AF97-04ECB6607265Q37935774-9B84FDC4-B301-49A6-9CF1-881710377735Q52609630-0BC8F42D-D1CC-4B6E-A1BD-DDAA63C065C8Q53085054-F0F18972-9DCB-40C3-8E2C-847A4AD115AA
P2860
The 4Ts scoring system for heparin-induced thrombocytopenia in medical-surgical intensive care unit patients.
description
2010 nî lūn-bûn
@nan
2010 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
The 4Ts scoring system for hep ...... intensive care unit patients.
@ast
The 4Ts scoring system for hep ...... intensive care unit patients.
@en
type
label
The 4Ts scoring system for hep ...... intensive care unit patients.
@ast
The 4Ts scoring system for hep ...... intensive care unit patients.
@en
prefLabel
The 4Ts scoring system for hep ...... intensive care unit patients.
@ast
The 4Ts scoring system for hep ...... intensive care unit patients.
@en
P2093
P50
P1476
The 4Ts scoring system for hep ...... intensive care unit patients.
@en
P2093
Canadian Critical Care Trials Group
Christian Rabbat
David Williamson
Deborah J Cook
James Douketis
Joanne Sheppard
John Granton
Mark Andrew Crowther
Martin Albert
Maureen Meade
P304
P356
10.1016/J.JCRC.2009.12.006
P577
2010-02-10T00:00:00Z